Edward Kaye is the founder of Stoke Therapeutics. Stoke Therapeutics has raised $40M in total funding. Latest round: Series A. Backed by Apple Tree Partners.
Edward Kaye is the former CEO of Sarepta Therapeutics who became the leader of Stoke Therapeutics when the biotechnology company launched in 2018. He served as CEO at the helm of Stoke Therapeutics, a company focused on increasing gene expression to treat severe genetic diseases. Stoke Therapeutics later became a publicly-traded company in 2019.
Full founder directory · Investor directory · Company funding database · Fundraising library